{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:14:11Z","timestamp":1790172851492,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Iowa Osteopathic Education and Research Fund"},{"DOI":"10.13039\/100012579","name":"Iowa Science Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012579","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.virusres.2018.03.015","type":"journal-article","created":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T13:18:31Z","timestamp":1522243111000},"page":"93-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Herpes simplex virus virucidal activity of MST-312 and epigallocatechin gallate"],"prefix":"10.1016","volume":"249","author":[{"given":"Prajakta","family":"Pradhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie L.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virusres.2018.03.015_bib0005","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.2217\/fvl.15.85","article-title":"Cell entry mechanisms of HSV: what we have learned in recent years","volume":"10","author":"Agelidis","year":"2015","journal-title":"Future Virol."},{"key":"10.1016\/j.virusres.2018.03.015_bib0010","article-title":"Herpes simplex virus: propagation, quantification, and storage","volume":"Unit 14E.1","author":"Blaho","year":"2005","journal-title":"Curr. Protoc. Microbiol."},{"key":"10.1016\/j.virusres.2018.03.015_bib0015","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S0006-291X(03)00067-6","article-title":"Inhibition of Epstein-Barr virus lytic cycle by (-)-epigallocatechin gallate","volume":"301","author":"Chang","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.virusres.2018.03.015_bib0020","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.bbrc.2011.12.104","article-title":"EGCG debilitates the persistence of EBV latency by reducing the DNA binding potency of nuclear antigen 1","volume":"417","author":"Chen","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.virusres.2018.03.015_bib0025","first-page":"53","article-title":"Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E","volume":"10","author":"Chow","year":"2001","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.virusres.2018.03.015_bib0030","first-page":"3312","article-title":"Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals","volume":"9","author":"Chow","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.virusres.2018.03.015_bib0035","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/hep.24610","article-title":"The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry","volume":"54","author":"Ciesek","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.virusres.2018.03.015_bib0040","doi-asserted-by":"crossref","first-page":"7806","DOI":"10.1128\/JVI.00896-14","article-title":"A small molecule inhibits virion attachment to heparan sulfate- or sialic acid-containing glycans","volume":"88","author":"Colpitts","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2018.03.015_bib0045","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s002800050903","article-title":"Pharmacokinetics of the green tea derivative, EGCG, by the topical route of administration in mouse and human skin","volume":"43","author":"Dvorakova","year":"1999","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.virusres.2018.03.015_bib0050","doi-asserted-by":"crossref","first-page":"9804","DOI":"10.1128\/JVI.01006-15","article-title":"The telomerase inhibitor MST-312 interferes with multiple steps in the herpes simplex virus life cycle","volume":"89","author":"Haberichter","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2018.03.015_bib0055","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1128\/AAC.00825-07","article-title":"Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus","volume":"52","author":"Isaacs","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virusres.2018.03.015_bib0060","first-page":"1025","article-title":"Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability","volume":"11","author":"Lee","year":"2002","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.virusres.2018.03.015_bib0065","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1128\/AAC.00615-10","article-title":"Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management","volume":"55","author":"Piret","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virusres.2018.03.015_bib0070","series-title":"Fields Virology","first-page":"1823","article-title":"Herpes simplex viruses","author":"Roizman","year":"2013"},{"key":"10.1016\/j.virusres.2018.03.015_bib0075","first-page":"657","article-title":"Telomere shortening and growth inhibition of human cancer cells by novel synthetic telomerase inhibitors MST-312, MST-295, and MST-1991","volume":"1","author":"Seimiya","year":"2002","journal-title":"Mol. Cancer. Ther."},{"key":"10.1016\/j.virusres.2018.03.015_bib0080","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.antiviral.2005.06.010","article-title":"Antiviral effect of catechins in green tea on influenza virus","volume":"68","author":"Song","year":"2005","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virusres.2018.03.015_bib0085","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1086\/338231","article-title":"Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis","volume":"185","author":"Wald","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virusres.2018.03.015_bib0090","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1750-3639.2010.00372.x","article-title":"Telomerase inhibition as a novel therapy for pediatric ependymoma","volume":"20","author":"Wong","year":"2010","journal-title":"Brain Pathol."},{"key":"10.1016\/j.virusres.2018.03.015_bib0095","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0166-3542(01)00189-9","article-title":"Inhibitory effects of (-)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1)","volume":"53","author":"Yamaguchi","year":"2002","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virusres.2018.03.015_bib0100","first-page":"351","article-title":"Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers","volume":"7","author":"Yang","year":"1998","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.virusres.2018.03.015_bib0105","first-page":"83","article-title":"Human salivary tea catechin levels and catechin esterase activities: implication in human cancer prevention studies","volume":"8","author":"Yang","year":"1999","journal-title":"Cancer Epidemiol. Biomark. Prev."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170217305373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170217305373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T19:51:17Z","timestamp":1534967477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170217305373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":21,"alternative-id":["S0168170217305373"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2018.03.015","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Herpes simplex virus virucidal activity of MST-312 and epigallocatechin gallate","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2018.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}